Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients

Table 1 Demographic characteristics and lung function indices

Variable	Characteristics	IPF patients (n = 15)	Healthy control	Healthy control
			Age 50 + (n = 30)	All (n = 87)
Age (years)	Mean ± STD	76 ± 6.94	56 ± 3.74	40 ± 13.32
	Range	65–89	50–69	19–69
Gender	Female	6	7	20
	Male	9	23	67
Lung function
FVC% predictive		73 ± 15.6
FEV1% predictive		85.2 ± 14.1
VC_max % predictive		74.2 ± 15.1
Treatment at immunophenotyping (n)
Pirfenidone		5
Nintedanib		2
Prednisone		1
No medications		7

Data are presented as mean ± SD, FVC% predictive = % of Forced Vital Capacity; FEV1% predictive = % of Forced Expiratory Volume in the 1st second, predictive; VC_max % predictive = % Maximal Vital capacity
“Predictive” means values adjusted for patient age, gender and race

ISSN: 1757-6512